Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer

OBJECTIVES: We previously reported the feasibility of neoadjuvant capecitabine and oxaliplatin plus bevacizumab as a treatment for locally advanced rectal cancer (UMIN000003219). The aim of this study is to investigate the prognostic relevance of neoadjuvant chemotherapy followed by total mesorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Junichi, Hasegawa, Junichi, Noura, Shingo, Ikeda, Kimimasa, Yasui, Masayoshi, Komori, Takamichi, Tsujie, Masaki, Yasumasa, Keigo, Shingai, Tatsushi, Uemura, Mamoru, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Ikeda, Masataka, Doki, Yuichiro, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Society of Coloproctology 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390618/
https://www.ncbi.nlm.nih.gov/pubmed/32743112
http://dx.doi.org/10.23922/jarc.2019-042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390618/
https://www.ncbi.nlm.nih.gov/pubmed/32743112
http://dx.doi.org/10.23922/jarc.2019-042

Ejemplares similares